DVT Certificates Offer Only Illusory Assurance as Long as Full Validation Is Missing

The article shows how design validation testing is often misinterpreted in practice, with serious consequences for safety and reliability. Colin Zegers warns that DVT as carried out according to MESC SPE 77/300 Appendix C only covers the testing section and does not make any statement about design validation, supplier control or an audit of the production site. Yet many end users regard a successful DVT test as full approval, whereas in reality roughly 60 to 70 percent of the valves fail these tests because of casting defects, gasket failures, stem-seal issues or leakage under extreme pressure and temperature conditions. This type of failure behaviour is identified during DVT programmes through controlled pressure testing under representative loads. This misconception results in valves being installed on the basis of incomplete assurance, increasing the risk of failure in the field.

Zegers positions a correct interpretation of DVT and strict adherence to the full MESC SPE 77/300 process as indispensable for demonstrable valve integrity. Appendix C is a necessary but limited instrument that only confirms whether a valve operates within its stated design limits during mechanical and thermal cycles; it does not indicate whether the entire design and production process complies with the required standards. As an independent test expert, Zegers emphasises that end users themselves must take responsibility for complete compliance and clear specifications, precisely because test results lose their value without context. Anyone wishing to understand where DVT ends and real design validation begins will find in the full article insights that have a direct impact on purchasing, risk control and operational safety.